EFFECTS OF DENOSUMAB ON PAIN AND ANALGESIC USE IN GIANT CELL TUMOUR OF BONE: RESULTS FROM A PHASE 2 STUDY

被引：0
作者：
Broto, J. [1 ]
Cleeland, C. [2 ]
Skubitz, K. [3 ]
Staddon, A. [4 ]
Blum, R. [5 ]
Dominkus, M. [6 ]
Engellau, J. [7 ]
Ganjoo, K. [8 ]
Atchison, C. [9 ]
Qian, Y. [9 ]
Jacobs, I. [9 ]
机构：
[1] Hosp Univ Son Espases, Palma De Mallorca, Spain
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[4] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[5] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA
[6] Med Univ Wien, Vienna, Austria
[7] Skane Univ Hosp, Lund, Sweden
[8] Stanford Univ, Ctr Canc, Stanford, CA 94305 USA
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [31] Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
    Palmerini, Emanuela
    Seeger, Leanne L.
    Gambarotti, Marco
    Righi, Alberto
    Reichardt, Peter
    Bukata, Susan
    Blay, Jean-Yves
    Dai, Tian
    Jandial, Danielle
    Picci, Piero
    BMC CANCER, 2021, 21 (01)
  • [32] Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
    Emanuela Palmerini
    Leanne L. Seeger
    Marco Gambarotti
    Alberto Righi
    Peter Reichardt
    Susan Bukata
    Jean-Yves Blay
    Tian Dai
    Danielle Jandial
    Piero Picci
    BMC Cancer, 21
  • [33] Denosumab and giant cell tumour of bone-a review and future management considerations
    Xu, S. F.
    Adams, B.
    Yu, X. C.
    Xu, M.
    CURRENT ONCOLOGY, 2013, 20 (05) : E442 - E447
  • [34] EFFICACY AND SAFETY OF DENOSUMAB IN GIANT CELL TUMOUR OF BONE (GCTB): UPDATED RESULTS WITH INDEPENDENT RADIOGRAPHIC ASSESSMENT OF RESPONSE
    Thomas, D.
    Blay, J. -Y.
    Chawla, S.
    Choy, E.
    Grimer, R.
    Ferrari, S.
    Reichardt, P.
    Rutkowski, P.
    Qian, Y.
    Jacobs, I.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 46 - 46
  • [35] Blue lacy matrix in giant cell tumour of bone with or without denosumab therapy
    Toda, Yu
    Ishihara, Shin
    Kawai, Akira
    Yoshida, Akihiko
    VIRCHOWS ARCHIV, 2023, 483 (01) : 125 - 129
  • [36] Blue lacy matrix in giant cell tumour of bone with or without denosumab therapy
    Yu Toda
    Shin Ishihara
    Akira Kawai
    Akihiko Yoshida
    Virchows Archiv, 2023, 483 : 125 - 129
  • [37] Denosumab has limited therapeutic effect on giant cell tumour of bone: a study of 7 recurrent cases
    Kato, I.
    Furuya, M.
    Kawabata, Y.
    Takeyama, M.
    Hayashida, K.
    Tanaka, R.
    Ohashi, K.
    VIRCHOWS ARCHIV, 2019, 475 : S407 - S407
  • [38] Denosumab as a neoadjuvant treatment for giant cell tumor of bone. Indications, results and side effects
    Latorre, Marcos R.
    Albergo, Jose, I
    Farfalli, German L.
    Roitman, Pablo D.
    Plantalech, Luisa
    Ayerza, Miguel A.
    Aponte-Tinao, Luis A.
    MEDICINA-BUENOS AIRES, 2021, 81 (05) : 767 - 773
  • [39] In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid
    Shibuya, Isao
    Takami, Masamichi
    Miyamoto, Arei
    Karakawa, Akiko
    Dezawa, Akira
    Nakamura, Shigeru
    Kamijo, Ryutaro
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 409 - 419
  • [40] Giant cell tumour of bone in the rib cage treated with denosumab. A case report
    Miralles, Paula Serret
    Fernandez, Ruth Orellana
    Parente, Tamara Parra
    Brigido, Rosa Belen Garcia-Chamon
    Salas, Ruben Carrera
    REVISTA ESPANOLA DE PATOLOGIA, 2023, 56 (02):
12345